Treatment of Pertussis in Elderly Patients

First-Line Antibiotic Therapy

The American College of Physicians recommends azithromycin as the first-line antibiotic for elderly patients with pertussis, due to its superior tolerability and shorter treatment duration, with a recommended dosing of 500 mg on day 1, followed by 250 mg daily on days 2-5, to eradicate Bordetella pertussis from the nasopharynx and prevent transmission to vulnerable contacts 1, 2
Azithromycin is the preferred macrolide for elderly patients due to its superior tolerability, shorter treatment duration, and significantly better compliance rates compared to erythromycin, with a strength of evidence supported by the American Thoracic Society 3, 1

The Infectious Diseases Society of America recommends clarithromycin as an alternative macrolide with comparable efficacy to azithromycin, with a dosing of 500 mg twice daily for 7 days, for patients who cannot tolerate azithromycin 1, 2
Trimethoprim-sulfamethoxazole is the recommended alternative for patients with macrolide contraindications or hypersensitivity, according to the Centers for Disease Control and Prevention 2

The American Academy of Family Physicians recommends starting antibiotics immediately upon clinical suspicion of pertussis, without waiting for culture confirmation, as early treatment can reduce symptom duration and severity by approximately 50%, with a strength of evidence supported by the American College of Chest Physicians 3, 1, 2
Even when started during the paroxysmal stage, antibiotics remain critical for eradicating the organism and preventing transmission, though clinical benefit to the patient is limited at this stage, according to the American Thoracic Society 3, 1

The Centers for Disease Control and Prevention recommend isolating the patient at home for 5 days after starting antibiotics to prevent transmission, as pertussis has a secondary attack rate exceeding 80% among susceptible household contacts 1, 2

The American Academy of Pediatrics recommends that all household and close contacts require macrolide antibiotic prophylaxis regardless of age or vaccination status, using the same regimens as for treatment, to prevent transmission to vulnerable contacts 1, 2
Prophylaxis should be administered within 21 days of exposure and is especially critical if contacts include infants <12 months, pregnant women in the third trimester, or other vulnerable individuals, according to the Centers for Disease Control and Prevention 2

The American College of Chest Physicians recommends avoiding the use of β-agonists, antihistamines, corticosteroids, or pertussis immunoglobulin, as these have no proven benefit in controlling coughing paroxysms or improving clinical outcomes 3, 1

Azithromycin should not be taken simultaneously with aluminum- or magnesium-containing antacids as they reduce absorption, according to the manufacturer's instructions 2
Use caution in patients with impaired hepatic function when using azithromycin, according to the American Association for the Study of Liver Diseases 2

The American Academy of Family Physicians recommends not delaying treatment waiting for laboratory confirmation—clinical suspicion alone warrants immediate antibiotic initiation, with a strength of evidence supported by the American College of Physicians 2
The American Thoracic Society recommends not assuming treatment is futile in the paroxysmal stage—while clinical benefit to the patient may be limited, treatment remains essential to prevent transmission to vulnerable contacts 3, 1

The American Geriatrics Society recommends watching for weight loss, sleep disturbance, and post-tussive vomiting, which occur frequently in elderly patients, to monitor for complications 1
Monitor for pressure-related effects from severe coughing including pneumothorax, epistaxis, subconjunctival hemorrhage, and rib fractures, according to the American College of Emergency Physicians 1